Skip to main content
. 2017 Feb 22;24(4):806–812. doi: 10.1093/jamia/ocx010

Table 2.

Pairwise comparison showing number of overlapping clinical drug pairs (numbers in thousands) between KBs

graphic file with name ocx010ilf1.jpg

Each pairwise comparison is outlined by thick borders. The percentages are based on row totals (KB1). The highest percentage (excluding “not found”) in each severity category is highlighted in bold type. Shaded boxes are those in which the severity rankings in 2 KBs agree (sev1 = contraindicated, sev2 = major/severe, sev3 = moderate).